Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children Cohort Study)

Journal of the American College of Cardiology

Volumn 57, Issue 1, 2011, Pages 76-85

  Lipshultz, Steven E ^a   Shearer, William T ^b   Thompson, Bruce ^d   Rich, Kenneth C ^e   Cheng, Irene ^d   Orav, E John ^f   Kumar, Sulekha ^e   Pignatelli, Ricardo H ^c   Bezold, Louis I ^c   Larussa, Philip ^g   Starc, Thomas J ^g   Glickstein, Julie S ^g   OBrien, Sharon ^h   Cooper, Ellen R ^h   Wilkinson, James D ^a   Miller, Tracie L ^a   Colan, Steven D ⁱ  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Clinical Trials & Surveys Corp   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h BOSTON MEDICAL CENTER   (United States)

ⁱ BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

antiretroviral therapy; cardiomyopathy; HIV; pediatric

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CARDIOVASCULAR FUNCTION; CHILD; CHILD HEALTH; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; NEWBORN; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; THICKNESS;

EID: 78650534363     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.08.620     Document Type: Article

References (45)

1. L.M. Luginbuhl, E.J. Orav, K. McIntosh, and S.E. Lipshultz Cardiac morbidity and related mortality in children with HIV infection JAMA 269 1993 2869 2875
2. 2 HIV multicenter study Circulation 97 1998 1246 1256
3. I. Al-Attar, E.J. Orav, V. Exil, S.A. Vlach, and S.E. Lipshultz Predictors of cardiac morbidity and related mortality in children with acquired immunodeficiency syndrome J Am Coll Cardiol 41 2003 1598 1605
4. 2 HIV multicenter study Circulation 102 2000 1542 1548
5. 2 HIV multicenter study Am Heart J 150 2005 439 447
6. 2 HIV): a cohort study Lancet 360 2002 368 373
7. S. Blanche, M. Tardieu, and P. Rustin Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues Lancet 354 1999 1084 1089
8. C. Foster, and H. Lyall HIV and mitochondrial toxicity in children J Antimicrob Chemother 61 2008 8 12
9. C. Thorne, and M.L. Newell Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern? Drug Saf 30 2007 203 213
10. N. Suksomboon, N. Poolsup, and S. Ket-Aim Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection J Clin Pharm Ther 32 2007 293 311
11. S.E. Lipshultz, E.J. Orav, S.P. Sanders, A.R. Hale, K. McIntosh, and S.D. Colan Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine N Engl J Med 327 1992 1260 1265
12. S.E. Lipshultz, K.A. Easley, and E.J. Orav Absence of cardiac toxicity of zidovudine in infants N Engl J Med 343 2000 759 766
13. E.R. Cooper, M. Charurat, and L. Mofenson Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission J Acquir Immune Defic Syndr 29 2002 484 494
14. J.E. Lavigne, W.T. Shearer, B. Thompson CHAART Study Group Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study Cardiovasc Toxicol 4 2004 187 198
15. W.T. Shearer, T.C. Quinn, P. LaRussa Women and Infants Transmission Study Group Viral load and disease progression in infants infected with human immunodeficiency virus type 1 N Engl J Med 335 1997 1337 1342
16. 2 HIV) infection study: design and methods J Clin Epidemiol 49 1996 1285 1294
17. 2 HIV study Circulation 104 2001 310 316
18. K.Y. Liang, and S.L. Zeger Longitudinal data analysis using generalized linear models Biometrika 73 1986 13 22
19. 2 HIV study: the role of EBV shedding J Acquir Immune Defic Syndr Hum Retrovirol 19 1998 462 470
20. S.E. Lipshultz, S.D. Colan, R.D. Gelber, A.R. Perez-Atayde, S.E. Sallan, and S.P. Sanders Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood N Engl J Med 324 1991 808 815
21. S.E. Lipshultz, S.R. Lipsitz, and S.M. Mone Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer N Engl J Med 332 1995 1738 1743
22. S.E. Lipshultz, S.R. Lipsitz, and S.E. Sallan Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia J Clin Oncol 23 2005 2629 2636
23. S.M. Torres, T.H. March, and M.M. Carter In utero exposure of female CD-1 mice to AZT and/or 3TC: I Persistence of microscopic lesions in cardiac tissue Cardiovasc Toxicol 10 2010 37 50
24. S.M. Torres, R.L. Divi, and D.M. Walker In utero exposure of female CD-1 mice to AZT and/or 3TC: II Persistence of functional alterations in cardiac tissue Cardiovasc Toxicol 10 2010 87 99
25. S.M. Torres, D.M. Walker, and C.L. McCash Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1 Environ Mol Mutagen 50 2009 10 26
26. S.E. Lipshultz, V.E. Walker, and S.M. Torres Frequent mitochondrial DNA mutations and polymorphisms in long-term survivors of childhood acute lymphoblastic leukemia Blood 118 2007 824A
27. S.E. Lipshultz, V.C. Simbre, and S. Hart Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns Am J Cardiol 102 2008 761 766
28. F. Gotsch, R. Romero, and J.P. Kusanovic The fetal inflammatory response syndrome Clin Obstet Gynecol 50 2007 652 683
29. D.J. Dhasmana, K. Dheda, P. Ravn, R.J. Wilkinson, and G. Meintjes Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management Drugs 68 2008 191 208
30. W.T. Shearer, S.E. Lipshultz, and K. Easley Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors Pediatrics 105 2000 1 8
31. S.S. Chan, J.H. Santos, and J.N. Meyer Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination Environ Mol Mutagen 48 2007 190 200
32. A.C. Mertens, Y. Yasui, and J.P. Neglia Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study J Clin Oncol 19 2001 3163 3172
33. K.C. Oeffinger, A.C. Mertens, and C.A. Sklar Chronic health conditions in adult survivors of childhood cancer N Engl J Med 355 2006 1572 1582
34. H.H. Chow, P. Li, G. Brookshier, and Y. Tang In vivo tissue disposition of 3′-azido-3′-deoxythymidine and its anabolites in control and retrovirus-infected mice Drug Metab Dispos 25 1997 412 422
35. S.B. Brogley, N. Ylitalo, and L.M. Mofenson In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children AIDS 21 2007 929 938
36. European Collaborative Study Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women J Acquir Immune Defic Syndr 32 2003 380 387
37. B. Barret, M. Tardieu, and P. Rustin Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort AIDS 17 2003 1769 1785
38. M.H. Godfried, K. Boer, S. Beuger, H.J. Scherpbier, and T.W. Juijpers A neonate with macrosomia, cardiomyopathy, and hepatomegaly born to an HIV-infected mother Eur J Pediatr 164 2005 190 192
39. D.M. Walker, M.C. Poirier, and M.J. Campen Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine Cardiovasc Toxicol 4 2004 133 153
40. M. Culnane, M. Fowler, and S.S. Lee Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams JAMA 281 1999 151 157
41. The Perinatal Safety Review Working Group Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts J Acquir Immune Defic Syndr 25 2000 261 268
42. L. Mofenson, and P. Munderi Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants J Acquir Immune Defic Syndr 30 2002 200 215
43. S.E. Pacheco, K. McIntosh, M. Lu Women and Infants Transmission Study Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: an analysis of the women and infants transmission study J Infect Dis 194 2006 1089 1097
44. K.L. Witt, C.K. Cunningham, and K.B. Patterson Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV Environ Mol Mutagen 48 2007 322 329
45. C. Feiterna-Sperling, K. Weizsaecker, and C. Buhrer Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants J Acquir Immune Defic Syndr 45 2007 42 51